27 Sep 2021
Vaxinano technology used in development of COVID-19 nasal vaccine
By Staff Writer
Vaxinano is pleased to announce that a nanoparticulate vaccine against COVID-19 has demonstrated positive preclinical results. The company continues to confirm its efficacy with its world renowned nanoparticulate delivery system by nasal vaccine administration. This technology has already confirmed its effectiveness, especially in the fight against deadly toxoplasmosis in primates. Protection against viral infections This...
